Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Philip Hampton

Newcastle AuthorsTitleYearFull text
Dr Philip Hampton
Minimum dataset for treatment effectiveness in pyoderma gangrenosum for an international registry: an international multidisciplinary eDelphi consensus2026
Dr Batoul Nasr
Dr Philip Hampton
A patient with blistering eruption in skin of colour2025
Dr Philip Hampton
Adalimumab Monotherapy vs Adalimumab with Methotrexate for Psoriasis2025
Professor Nick Reynolds
Dr Philip Hampton
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study2025
Dr Philip Hampton
Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosum2025
Dr Amaani Hussain
Dr Sophie Weatherhead
Professor Nick Reynolds
Dr Philip Hampton
Adopting a personalized approach to blood monitoring in patients with psoriasis prescribed biologic therapy: a retrospective single-centre review of real-world data2024
Dr Philip Hampton
An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum2024
Dr Philip Hampton
Current prescribing for pyoderma gangrenosum in the UK and access to biologic medications: Results from a UK Dermatology Clinical Trials Network survey of dermatologists2024
Dr Beth Poyner
Emily Stephenson
Dr Louis Gardner
Dr Bayanne Olabi
Dr Hudaa Gopee
et al.		Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment2024
Dr Philip Hampton
Patient-led skin cancer teledermatology without dermoscopy during the COVID-19 pandemic: important lessons for the development of future patient-facing teledermatology and artificial intelligence-assisted -self-diagnosis2024
Dr Amaani Hussain
Dr Philip Hampton
Improving the Accuracy of Biologic Drug Survival Data: The Increasing Prevalence of Off-Label Dosing Must Be Considered when Reporting Drug Effectiveness and Safety2023
Dr Philip Hampton
Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiative2023
Dr Katie Best
Dr Simon Meggitt
Dr Philip Hampton
P103 A retrospective observational study of toxic epidermal necrolysis at a tertiary referral centre from 2015 to 20222023
Dr Philip Hampton
Pyoderma Gangrenosum: Treatment Options2023
Dr Katie Best
Dr Anna Dubois
Dr Philip Hampton
Bullous pemphigoid triggered by COVID‐19 vaccination: two cases treated with immunosuppression2022
12